Emily J. Rowling

876 total citations
8 papers, 429 citations indexed

About

Emily J. Rowling is a scholar working on Oncology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Emily J. Rowling has authored 8 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Emily J. Rowling's work include Cancer-related Molecular Pathways (4 papers), Cell death mechanisms and regulation (2 papers) and Cell Adhesion Molecules Research (2 papers). Emily J. Rowling is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Cell death mechanisms and regulation (2 papers) and Cell Adhesion Molecules Research (2 papers). Emily J. Rowling collaborates with scholars based in United Kingdom, United States and Switzerland. Emily J. Rowling's co-authors include Claudia Wellbrock, Michael P. Smith, Jennifer Ferguson, Zsofia Miskolczi, Jann N. Sarkaria, Nicola J. Curtin, Adam P. Hopkins, William A. Cliby, Gary Beale and Richard J. Edmondson and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Clinical Endocrinology & Metabolism and Oncogene.

In The Last Decade

Emily J. Rowling

8 papers receiving 425 citations

Peers

Countries citing papers authored by Emily J. Rowling

Since Specialization

Citations

This map shows the geographic impact of Emily J. Rowling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily J. Rowling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily J. Rowling more than expected).

Fields of papers citing papers by Emily J. Rowling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily J. Rowling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily J. Rowling. The network helps show where Emily J. Rowling may publish in the future.

Co-authorship network of co-authors of Emily J. Rowling

This figure shows the co-authorship network connecting the top 25 collaborators of Emily J. Rowling. A scholar is included among the top collaborators of Emily J. Rowling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily J. Rowling. Emily J. Rowling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Cooperative behaviour and phenotype plasticity evolve during melanoma progression 2020 ·Pigment Cell & Melanoma Research ·Emily J. Rowling, Zsofia Miskolczi, Raghavendar T. Nagaraju, (unknown), Ping Wang, Brian A. Telfer, Yaoyong Li, Irene Otero, (unknown), Andrew D Sharrocks, Imanol Arozarena, Claudia Wellbrock	13
2	Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing 2018 ·Oncogene ·Zsofia Miskolczi, Michael P. Smith, Emily J. Rowling, Jennifer Ferguson, Jorge Barriuso, Claudia Wellbrock	84
3	A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITF^high/AXL^low melanoma 2018 ·Pigment Cell & Melanoma Research ·Michael P. Smith, Sareena Rana, Jennifer Ferguson, Emily J. Rowling, Keith T. Flaherty, Jennifer A. Wargo, Richard Marais, Claudia Wellbrock	31
4	An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition 2017 ·The Journal of Experimental Medicine ·Helen L. Young, Emily J. Rowling, (unknown), Emanuele Giurisato, Nadia Luheshi, Imanol Arozarena, Juan Carlos Acosta, Jivko Kamarashev, Dennie T. Frederick, Zachary A. Cooper, Alexandre Reuben, Jesús Gil, Keith T. Flaherty, Jennifer A. Wargo, William Vermi, Michael P. Smith, Claudia Wellbrock, Adam Hurlstone	75
5	Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas 2016 ·Oncotarget ·Natalie Burrows, Joseph Williams, Brian A. Telfer, Julia Resch, Helen Valentine, Richard J. Fitzmaurice, Amanda Eustace, Joely J. Irlam, Emily J. Rowling, Cuong Hoang‐Vu, Catharine West, Georg Brabant, Kaye J. Williams	10
6	Detection of apoptosis by PET/CT with the diethyl ester of [18F]ML-10 and fluorescence imaging with a dansyl analogue 2013 ·Bioorganic & Medicinal Chemistry ·Manikandan Kadirvel, (unknown), Christopher Cawthorne, Emily J. Rowling, Muhammad Babur, Adam McMahon, (unknown), Alison Smigova, Sally Freeman, Kaye J. Williams, Gavin Brown	14
7	Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines 2011 ·British Journal of Cancer ·(unknown), (unknown), Emily J. Rowling, Suzanne Kyle, (unknown), Adam P. Hopkins, William A. Cliby, Jann N. Sarkaria, Gary Beale, Richard J. Edmondson, Nicola J. Curtin	152
8	GDC-0941 Inhibits Metastatic Characteristics of Thyroid Carcinomas by Targeting both the Phosphoinositide-3 Kinase (PI3K) and Hypoxia-Inducible Factor-1α (HIF-1α) Pathways 2011 ·The Journal of Clinical Endocrinology & Metabolism ·Natalie Burrows, Muhammad Babur, Julia Resch, (unknown), (unknown), Emily J. Rowling, Georg Brabant, Kaye J. Williams	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact